For Alzheimer's Agitation, Promising News from Rexulti (Brexpiprazole)
Por um escritor misterioso
Descrição
Rexulti (brexpiprazole) shares positive trial results for treating agitation in Alzheimer's. Following this a bumpy road for another Alzheimer's drug candidate that could supplant the need for antipsychotics to treat behavioral Alzheimer's symptoms, this could be the first such drug approved — if its safety and efficacy data stay on track.
FDA Advisors Endorse Rexulti for Agitation in Alzheimer's Dementia
Dementia Treatment - Hallucinations & Agitation Treatment
Alzheimer's Disease Insight Report: Current Therapies, Drug
Brexpiprazole (Rexulti) Approved for Alzheimer's Agitation
Brexpiprazole Eases Agitation in People with AD; So Does Being in
Dementia: FDA fast-tracks approval for antipsychotic drug Rexulti
FDA Approves Rexulti for Agitation Associated With Dementia Due to
Brexpiprazole - Wikipedia
Not Everyone Agreed With FDA Approval of Antipsychotic Rexulti for
Lundbeck, Otsuka drug cut agitation in Alzheimer's patients
Otsuka and Lundbeck Announce U.S. Food and Drug Administration
